Novo Nordisk has introduced Wegovy, a once-weekly weight loss injection, in India. The drug aims to manage obesity and reduce ...

Wegovy is the first drug in India approved for both weight management and risk reduction of major adverse cardiovascular events in individuals with established heart disease.

Danish pharma giant Novo Nordisk’s announcement comes months after launch of another top selling obesity drug Mounjaro in ...

Shiru is inviting partners to harness its AI-powered ingredient discovery platform to explore ingredients that naturally ...

NHS to monitor the mass rollout that will see around 220,000 people with the "greatest need" receive the weight loss jabs.

What happens if you stop GLP-1 weight loss injections like semaglutide and tirzepatide? Dr Bernard Tan from Bay Medical ...

What is Mounjaro, how does the weight-loss jab work and are you eligible for prescription from your GP? - From June 23, the ...

GPCRs (G-protein [guanine nucleotide-binding protein]–coupled receptors) play a central physiological role in the regulation of cardiac function in both health and disease and thus represent one of ...

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

In the present study, a model for the human gonadotropin-releasing hormone receptor embedded in an explicit lipid bilayer was developed. The final conformation was obtained by extensive molecular ...

In a world increasingly turning to pharmaceuticals for weight loss and metabolic control, a quieter contender is re-entering ...